Clinical Trials in Ohio

Showing 2481-2500 of 10,042 trials

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear

NCT06161012

This will be a multi-site, bilateral, dispensing, randomized, controlled, double-masked, 2×2 crossover study to evaluate ocular physiological response.

Ocular Physiology

Johnson & Johnson Vision Care, Inc.67 participantsStarted Nov 2023

Longwood, Florida, United States • Maitland, Florida, United States • Granville, Ohio, United States +3 more locations

Active Not Recruiting27 miles

Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy

NCT07024862

The study will assess the long-term real-world outcomes among adults diagnosed with programmed death-ligand 1 (PD-L1) \<1% metastatic non-small cell lung cancer (mNSCLC) treated with first-line (1L) nivolumab + ipilimumab + 2 cycles of chemotherapy (NIC) in the US

Metastatic Non-small Cell Lung Cancer

Bristol-Myers Squibb100 participantsStarted Oct 2024

Dublin, Ohio, United States

COMPLETEDPhase 230 miles

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

NCT06603220

This phase 2a trial will evaluate the safety and efficacy of EVO756 in subjects with chronic inducible urticaria, including symptomatic dermographism and cold urticaria.

Chronic Inducible Urticaria

Evommune, Inc.30 participantsStarted Aug 2024

Birmingham, Alabama, United States • Los Angeles, California, United States • Sacramento, California, United States +15 more locations

Evaluation of Delefilcon A and Senofilcon A Daily Disposable Toric Soft Contact Lenses Over Two Weeks of Wear

Long-term Outcomes Among Patients With Programmed Death-ligand 1 <1% Metastatic Non-small Cell Lung Cancer Treated With First-line Nivolumab + Ipilimumab + 2 Cycles of Chemotherapy

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria

Find Trials by Condition in Ohio

Efficacy and Safety of Nerinetide in Participants With Acute Ischemic Stroke Undergoing Endovascular Thrombectomy Excluding Thrombolysis

Inflammatory Challenge in Human Aggression.

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

A Study to Evaluate the Safety and Efficacy of K-321 Eye Drops After Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

A Study for Kidney Transplant Recipients at High-Risk of Cytomegalovirus Infection

Multi-Center Adolescent Clavicle Fracture Trial: Operative vs. Non-Operative Treatment

Clinical Investigation of the Next-Generation Intraocular Lens

A Study of Ociperlimab With Tislelizumab Compared to Pembrolizumab in Participants With Untreated Lung Cancer

Dose Escalation and Dose Expansion Study of Tirabrutinib in Combination With Other Targeted Anti-cancer Therapies in Adults With B-cell Malignancies

A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above

Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094

RemI for Post-Bariatric Surgery Weight Regain

Evaluation of the MiniMed™ 780G System in Type 1 Adult and Pediatric Subjects Utilizing Insulin Fiasp®

A Rollover Study to Further Evaluate the Safety and Efficacy of Palovarotene Capsules in Male and Female Participants Aged ≥14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed the Relevant Parent Studies.

EluPro Antibiotic-Eluting BioEnvelope Registry

A First-in-human Study to Evaluate the Safety, Tolerability and Pharmacokinetics of DS-6051b

Proton Radiation Therapy (RT) for the Treatment of Pediatric Rhabdomyosarcoma